A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

All of these questions deserve urgent exploration. Unfortunately, the discovery comes at a particularly difficult moment for ...

Some cancer patients who took 'checkpoint inhibitors' and received the COVID-19 vaccine saw surprising results.

The study builds on Dr Elias Sayour’s (University of Florida) earlier research and marks a key step toward a universal cancer vaccine that boosts immunotherapy’s effectiveness.

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing ...

A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate ...

Moderna swung to a loss and logged lower sales in the third quarter as it works to expand its offerings amid weakening demand ...

A: A Democratic proposal would restore almost $5 billion in unused funding for foreign aid that President Donald Trump let expire on Sept. 30. The proposal did not specify which international projects ...